home · filing · 0001104659-22-010000
8-K filed February 1, 2022, 6:59 PM ET
ticker KPRX
CIK 0001372514
leadership
confidence high
sentiment neutral
materiality 0.60
Kiora Pharmaceuticals appoints Erin Parsons to board; Stephen From resigns as Executive Chairman
KIORA PHARMACEUTICALS INC
Stephen From voluntarily resigned as Executive Chairman and board member effective Jan 31, 2022; no disagreement cited.
From receives 18 monthly severance payments of $33,333, a lump sum of $300,000, COBRA subsidies, and accelerated vesting.
Erin Parsons appointed as independent Class III director; she founded Parsons Medical Communications and has ophthalmic expertise.
Paul Chaney appointed as non-executive Chairman, previously serving as Lead Independent Director.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2022-01-31
Filed February 1, 2022, 6:59 PM ET
the Board appointed Paul Chaney as non-executive Chairman of the Board
Effective 2022-01-31
Filed February 1, 2022, 6:59 PM ET
On January 31, 2022, the Board of Directors (the “Board”) of Kiora Pharmaceuticals, Inc. (the “Company”) appointed Erin Parsons as a member of the Board.
Effective 2022-01-31
Successor Paul Chaney
Filed February 1, 2022, 6:59 PM ET
Effective of January 31, 2022, Stephen From voluntarily resigned as Executive Chairman of the Company and as a member of the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paul Chaney was appointed as non-executive Chairman at KIORA PHARMACEUTICALS INC.
Action appointed
Role non-executive Chairman
Exact text from the filing
the Board appointed Paul Chaney as non-executive Chairman of the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Erin Parsons was appointed as Director at KIORA PHARMACEUTICALS INC.
Action appointed
Role Director
Exact text from the filing
On January 31, 2022, the Board of Directors (the “Board”) of Kiora Pharmaceuticals, Inc. (the “Company”) appointed Erin Parsons as a member of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Stephen From resigned as Executive Chairman at KIORA PHARMACEUTICALS INC.
Action resigned
Role Executive Chairman
Exact text from the filing
Effective of January 31, 2022, Stephen From voluntarily resigned as Executive Chairman of the Company and as a member of the Board.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-22-010000
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.